Tat'yana S Kruglova

6PUBLICATIONS
30CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Immunogenetics (incl. genetic immunology)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 11, 2023
The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting.

T S Kruglova, D S Fomina

|May 11, 2023
[Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies].

A A Roppelt, M S Lebedkina, A A Chernov

|Oct 26, 2022
[Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit].

U A Markina, D S Fomina, M S Lebedkina

|Oct 26, 2022
[Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients' treatment].

A I Khripun, A V Starshinin, Y O Antipova

|Oct 26, 2022
[Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19].

T S Kruglova, D S Fomina, N G Poteshkina

|Oct 22, 2020
Temporal Clinical and Laboratory Response to Interleukin-6 Receptor Blockade With Tocilizumab in 89 Hospitalized Patients With COVID-19 Pneumonia.

Daria S Fomina, Mar'yana A Lysenko, Irina P Beloglazova

Pageof 1

Frequent Collaborators

6 joint publications

Daria S Fomina

5 joint publications

Anton A Chernov

5 joint publications

Mar'yana A Lysenko

3 joint publications

Alexander V Karaulov